Liu, J., Xie, Y., Guo, J., Li, X., Wang, J., Jiang, H., . . . Liu, Z. (2021). Targeting NSD2-mediated SRC-3 liquid–liquid phase separation sensitizes bortezomib treatment in multiple myeloma. Nature Portfolio.
Style de citation Chicago (17e éd.)Liu, Jing, et al. Targeting NSD2-mediated SRC-3 Liquid–liquid Phase Separation Sensitizes Bortezomib Treatment in Multiple Myeloma. Nature Portfolio, 2021.
Style de citation MLA (8e éd.)Liu, Jing, et al. Targeting NSD2-mediated SRC-3 Liquid–liquid Phase Separation Sensitizes Bortezomib Treatment in Multiple Myeloma. Nature Portfolio, 2021.
Attention : ces citations peuvent ne pas être correctes à 100%.